Amplifold is a biotech/medtech business that is developing next-generation quick diagnostic tests using DNA origami nanotechnology.
Amplifold has raised $5.8M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Amplifold's investors include Matterwave Ventures, Bayern Kapital, b2venture, XISTA Science Ventures, Becker Ventures.
Amplifold is headquartered in Munich, Germany.
Amplifold is a biotech/medtech business that is developing next-generation quick diagnostic tests using DNA origami nanotechnology.
Amplifold is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amplifold — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/amplifold. Accessed October 22, 2026.
VCBacked. (2025). Amplifold — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/amplifold
{{cite web |title=Amplifold — Funding & Investors |url=https://www.vcbacked.co/company/amplifold |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated